Literature DB >> 7665141

Hypertrophic cardiomyopathy--pathology and pathogenesis.

M J Davies1, W J McKenna.   

Abstract

Genes on five loci on separate chromosomes are responsible for a familial disease in which all or part of the ventricular muscle undergoes thickening with a histological picture of irregular hypertrophy and disorganized arrangement of myocytes (disarray). The three genes identified so far encode for beta heavy chain myosin (chromosome 14), troponin T (chromosome 1) and alpha tropomyosin (chromosome 15). It is postulated that the phenotype within the heart is produced by abnormal myofibril formation and alignment leading to an abnormal cell shape and, thus, disarray. While all the myocytes carry the gene, the regional selectivity of the hypertrophy is unexplained. The phenotypic expression of the disease within affected members of one family, all of whom are heterozygous for the same gene abnormality, is very varied. Asymptomatic carriers are common, and new mutations do not account for most apparently isolated cases. The phenotypic expression of the disease was studied in 75 hearts. The increase in total heart weight ranged from near normal to over 800 g. Ventricular involvement was diffuse and symmetric in 42%. The commonest asymmetric form involved the anteroseptal region (31%) but sporadic cases involved only the posterior or lateral wall. A minority of cases (9.5%) did not show macroscopic wall thickening. Fibrosis is often associated with dysplastic changes in the media of small intramyocardial arteries and may lead to the ventricular wall simulating a dilated cardiomyopathy. A subaortic patch of endocardial thickening on the ventricular septum due to contact with the anterior cusp of the mitral valve was found in a third of cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665141     DOI: 10.1111/j.1365-2559.1995.tb00267.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  31 in total

1.  Taking a bite out of hypertrophic cardiomyopathy: soy diet and disease.

Authors:  Cathy J Hatcher; Craig T Basson
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

Authors:  Briar R Ertz-Berger; Huamei He; Candice Dowell; Stephen M Factor; Todd E Haim; Sara Nunez; Steven D Schwartz; Joanne S Ingwall; Jil C Tardiff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

3.  Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014).

Authors:  J Rachel Reader; Don R Canfield; Jennifer F Lane; Sreetharan Kanthaswamy; Amir Ardeshir; A Mark Allen; Ross P Tarara
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

Review 4.  The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.

Authors:  J Burn; J Camm; M J Davies; L Peltonen; P J Schwartz; H Watkins
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

Review 5.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

Review 6.  Insights and challenges in hypertrophic cardiomyopathy, 2012.

Authors:  Srijita Sen-Chowdhry; María Teresa Tomé Esteban; William J McKenna
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-25

Review 7.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

8.  Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.

Authors:  J C Tardiff; T E Hewett; B M Palmer; C Olsson; S M Factor; R L Moore; J Robbins; L A Leinwand
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 9.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

10.  Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  Sherif F Nagueh; Suetnee Chen; Rajnikant Patel; Natalia Tsybouleva; Silvia Lutucuta; Helen A Kopelen; William A Zoghbi; Miguel A Quiñones; Robert Roberts; A J Marian
Journal:  J Mol Cell Cardiol       Date:  2004-05       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.